Since 2022, more than 6,000 women have had their exams passed through MIRAI and patients with increased breast cancer risk have been called for a differentiated screening program. Beyond the fact that these are important steps towards having a risk-based screening program implemented in Brazil's public health system, the opportunity for an early diagnosis is a life-changing factor for all these women! Dr. Grasiela Benini, MD
Head of Mastology & Mastology Residency Program Coordinator
Santa Marcelina Hospital

At IRST, we firmly believe that integrating deep learning technologies like SYBIL and MIRAI in clinical practice, will radically improve patient care. The use of AI algorithms by physicians and medical physicists can capture this opportunity and lead to the future of precision medicine because the utilization of imaging data is now only partially exploiting its full potential. Dr. Giacomo Feliciani, PhD
Medical Physics Unit
IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” IRST

In Chile, there are no cancer screening policies as defined by the WHO, only recommendations and for some types of cancers, financial coverage for the population. Therefore, there are tremendous opportunities regarding cancer prevention and early detection, especially for lower income people. Dr. Arnaldo Marín
PhD Faculty of Medicine, Department of Basic and Clinical Oncology
University of Chile